Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 9.43
+0.05 (0.53%)
Apr 28, 2026, 3:00 PM CST
SHA:603707 Market Cap
SHA:603707 has a market cap or net worth of 15.15 billion as of April 28, 2026. Its market cap has decreased by -35.09% in one year.
Market Cap
15.15B
Enterprise Value
14.88B
Revenue
3.76B
Ranking
n/a
PE Ratio
23.35
Stock Price
9.43
Market Cap Chart
Since July 19, 2017, SHA:603707's market cap has increased from 4.40B to 15.15B, an increase of 244.74%. That is a compound annual growth rate of 15.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 15.15B | 3.88% |
| Dec 31, 2025 | 14.59B | -31.95% |
| Dec 31, 2024 | 21.44B | -11.29% |
| Dec 29, 2023 | 24.17B | -16.87% |
| Dec 30, 2022 | 29.08B | -44.15% |
| Dec 31, 2021 | 52.06B | 59.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ApicHope Pharmaceutical Group | 17.19B |
| Shenzhen Kangtai Biological Products | 15.68B |
| Guangdong Zhongsheng Pharmaceutical | 15.60B |
| Shanghai Haoyuan Chemexpress | 15.20B |
| Shenzhen Hepalink Pharmaceutical Group | 14.57B |
| Beijing Aosaikang Pharmaceutical | 14.48B |
| Zhejiang Medicine | 14.04B |
| Guobang Pharma | 13.41B |